EC9706

EC9706 is a human esophageal squamous cell carcinoma cell line that was originally derived from a primary tumor of a 62-year-old male patient in China. This cell line is commonly used in research studies to understand the molecular mechanisms underlying esophageal cancer progression and to develop new treatment strategies.

EC9706 cells exhibit characteristics of squamous cell carcinoma, including the ability to form 3D spheroids in culture and the expression of markers such as cytokeratins. These cells have been shown to be responsive to various chemotherapeutic agents and targeted therapies, making them a valuable tool for drug testing and screening.

Overall, EC9706 cell line serves as an important model for studying esophageal cancer biology and testing potential therapeutic interventions, ultimately contributing to the development of novel treatments for this aggressive disease.